荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02509 荃信生物-B

已收盘 06-10 16:09:07

15.380

+0.410

+2.74%

最高15.380	最低14.410	成交量16.06万
今开15.010	昨收14.970	日振幅6.48%
总市值34.45亿	流通市值34.45亿	总股本2.24亿
成交额236.89万	换手率0.07%	流通股本2.24亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02509","market":"HK","secType":"STK","nameCN":"荃信生物-B","latestPrice":15.38,"timestamp":1781078947006,"preClose":14.97,"halted":0,"volume":160600,"delay":0,"changeRate":0.027388109552438217,"floatShares":224000000,"shares":224000000,"eps":1.41,"marketStatus":"已收盘","change":0.41,"latestTime":"06-10 16:09:07","open":15.01,"high":15.38,"low":14.41,"amount":2368866,"amplitude":0.064796,"askPrice":15.38,"askSize":600,"bidPrice":15.3,"bidSize":5000,"shortable":3,"etf":0,"ttmEps":1.564286,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781141400000},"marketStatusCode":5,"adr":0,"listingDate":1710864000000,"exchange":"SEHK","adjPreClose":14.97,"openAndCloseTimeList":[[1781055000000,1781064000000],[1781067600000,1781078400000]],"volumeRatio":0.543375,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02509/wiki","defaultTab":"wiki","newsList":[{"id":"1170780645","title":"荃信生物-B：6月10日回购66,600股股份，总金额约99.15万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1170780645","media":"公告速递","labels":["shareholding","SGX"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170780645?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:22","pubTimestamp":1781086925,"startTime":"0","endTime":"0","summary":"2026年6月10日，荃信生物-B公布翌日披露报表，披露于香港联交所场内回购66,600股H股普通股，约占回购前已发行股份总数的0.0298%。本次回购的价格区间为每股14.47港元至15.38港元，合计支付约99.15万港元。本次股份回购完成后，荃信生物-B已发行股份变动为223,575,800股，相应库藏股数量上升至3,495,800股，总已发行股份仍为227,071,600股。公司称，此次回购系根据2026年5月29日通过的股份回购授权进行，授权可回购股份总数为22,436,340股。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B：6月10日回购66,600股股份，总金额约99.15万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642644773","title":"荃信生物-B(02509)6月10日斥资99.15万港元回购6.66万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642644773","media":"智通财经网","labels":["shareholding"],"top":1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642644773?lang=zh_cn&edition=full","pubTime":"2026-06-10 18:18","pubTimestamp":1781086687,"startTime":"0","endTime":"0","summary":"荃信生物-B(02509)发布公告，于2026年6月10日，该公司斥资99.15万港元回购6.66万股股份，每股回购价14.47-15.38港元。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_42.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_42.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452658.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B(02509)6月10日斥资99.15万港元回购6.66万股","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143924298","title":"荃信生物-B自去年11月6日至今年6月9日回购343万股作库存股","url":"https://stock-news.laohu8.com/highlight/detail?id=1143924298","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143924298?lang=zh_cn&edition=full","pubTime":"2026-06-09 23:56","pubTimestamp":1781020590,"startTime":"0","endTime":"0","summary":"6月9日（路透社）—— 荃信生物-B（02509.HK）宣布，公司于2025年11月6日至2026年6月9日期间，在公开市场回购了共计343万股普通股，并计划将这些股份作为库存股持有。此举通常反映了公司管理层对自身长期价值及发展前景的信心，并可能通过减少流通股数量来提升每股收益，为股东创造价值。该股后续动向值得投资者密切关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642629464","title":"荃信生物-B(02509)根据购回授权购回合共342.92万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2642629464","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642629464?lang=zh_cn&edition=full","pubTime":"2026-06-09 19:37","pubTimestamp":1781005061,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，本公司董事会认为本公司目前股价严重低估本公司的价值。凭借对本公司未来发展前景的充分信心及对本公司内在价值的高度认同，为持续增强市场对本公司的信心并提升本公司的投资价值，根据本公司股东于2025年6月20日及 2026年5月29日举行的股东周年大会上批准授予本公司董事的股份购回授权，本公司已于2025年11月6日至本公告日期在香港联合交易所有限公司购回合共342.92万股普通股作为库存股。所购回的股份占本公司于本公告日期的现有已发行股份总数约1.51%。于本公告日期，购回涉及的总金额为约6566万港元(不包括佣金及其他开支)。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130427417","title":"荃信生物-B：6月9日回购6.94万股，耗资约104.92万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1130427417","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1130427417?lang=zh_cn&edition=full","pubTime":"2026-06-09 18:13","pubTimestamp":1781000015,"startTime":"0","endTime":"0","summary":"江蘇荃信生物醫藥股份有限公司于2026年6月9日发布公告，宣布当日通过香港联交所场内回购股份。本次合计回购69,400股，占回购前公司已发行股份约0.031%，回购价格介乎每股14.75港元至15.40港元，共耗资1,049,223.9港元。公司已于2026年5月29日获得购回授权，可回购股份总数22,436,340股。公司确认，本次回购活动已遵守香港联交所主板上市规则及相关法规，公告由董事会秘书和联席公司秘书胡衍保签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"荃信生物-B：6月9日回购6.94万股，耗资约104.92万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143905786","title":"荃信生物-B6月8日回购3.5万股股份，总额约52.66万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1143905786","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143905786?lang=zh_cn&edition=full","pubTime":"2026-06-08 18:37","pubTimestamp":1780915062,"startTime":"0","endTime":"0","summary":"江蘇荃信生物醫藥股份有限公司于2026年6月8日发布翌日披露报表，宣布当日在香港联交所回购股份。根据公告，回购股份数量为35,000股，占本次回购前公司已发行股份223,746,800股的约0.0156%，回购价格介乎每股港币14.78元至15.30元，合计支付526,645港元，折合约52.66万港元。公司确认，上述回购事宜严格遵守香港联交所主板上市规则及相关法律法规，并由董事会秘书和联席公司秘书胡衍保签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"荃信生物-B6月8日回购3.5万股股份，总额约52.66万港元","news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641748594","title":"荃信生物-B(02509)6月8日斥资52.66万港元回购3.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641748594","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641748594?lang=zh_cn&edition=full","pubTime":"2026-06-08 18:32","pubTimestamp":1780914737,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2026年6月8日，该公司斥资52.66万港元回购3.5万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451502.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126871504","title":"荃信生物-B回购25.32万股股份，耗资约382.60万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126871504","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126871504?lang=zh_cn&edition=full","pubTime":"2026-06-05 20:31","pubTimestamp":1780662710,"startTime":"0","endTime":"0","summary":"荃信生物-B于2026年6月5日发布翌日披露报表，公告显示公司于当日通过香港联交所场内回购253,200股H股，占回购前已发行股本约0.113%。回购价格介乎14.64港元至15.80港元，以每股成交量加权平均价15.1107港元计算，共耗资约382.60万港元。根据公告信息，公司于2026年5月29日获得购回授权，可回购的股份总数为22,436,340股，迄今已累计购回616,600股，占授权通过当日已发行股本的0.2748%。公司确认已遵守香港联交所主板上市规则及相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B回购25.32万股股份，耗资约382.60万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641110079","title":"荃信生物-B(02509)6月5日斥资382.6万港元回购25.32万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2641110079","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641110079?lang=zh_cn&edition=full","pubTime":"2026-06-05 20:27","pubTimestamp":1780662455,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2026年6月5日斥资382.6万港元回购25.32万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450950.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640157677","title":"荃信生物-B(02509)6月4日斥资39.19万港元回购2.52万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640157677","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640157677?lang=zh_cn&edition=full","pubTime":"2026-06-04 20:23","pubTimestamp":1780575792,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2026年6月4日斥资39.19万港元回购2.52万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1176256270","title":"荃信生物-B6月4日回购2.52万股，耗资约39.19万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1176256270","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1176256270?lang=zh_cn&edition=full","pubTime":"2026-06-04 20:22","pubTimestamp":1780575720,"startTime":"0","endTime":"0","summary":"江蘇荃信生物醫藥股份有限公司于2026年6月4日发布翌日披露报表，宣布在香港联交所场内回购25,200股H股。该批股份占回购前公司已发行股本约0.0112%，回购价格区间为每股15.31港元至15.80港元，合计支付金额391,865.04港元。本次回购完成后，公司已发行股份总数变动为224,000,000股，库藏股数量增至3,071,600股，总股份数保持在227,071,600股。荃信生物-B确认已遵守香港联交所证券上市规则及相关法例。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B6月4日回购2.52万股，耗资约39.19万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168474330","title":"荃信生物-B5月股份变动月报：完成204,200股回购，股本总数维持227,071,600股","url":"https://stock-news.laohu8.com/highlight/detail?id=1168474330","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168474330?lang=zh_cn&edition=full","pubTime":"2026-06-04 15:16","pubTimestamp":1780557407,"startTime":"0","endTime":"0","summary":"江蘇荃信生物醫藥股份有限公司于2026年6月4日发布截至2026年5月31日的股份变动月报。公告显示，公司法定注册股本维持人民币227,071,600元，与上期持平。根据月报，截至5月31日，荃信生物-B已发行股份数量为224,363,400股，库存股份数量为2,708,200股，两项合计为227,071,600股，与上月相比总股数保持不变。当月公司进行两次股份购回，其中在5月27日以每股16.3092港元回购134,200股，在5月28日以每股16.5227港元回购70,000股，合计回购204,200股并将上述股份作为库存股份持有。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184746328","title":"荃信生物-B 6月3日回购10.66万股，涉资约169.39万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1184746328","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184746328?lang=zh_cn&edition=full","pubTime":"2026-06-03 19:22","pubTimestamp":1780485741,"startTime":"0","endTime":"0","summary":"江蘇荃信生物醫藥股份有限公司于2026年6月3日发布公告，披露当日于香港联交所回购106,600股H股股份，占回购前公司已发行股本约0.0476%。本次回购每股价格介乎每股15.25港元至16.3港元，合计动用资金约169.39万港元。本次股份回购完成后，公司已发行股份由224,131,800股变为224,025,200股，库藏股增至3,046,400股，公司总已发行股份数维持227,071,600股。公司于公告中确认已遵守香港联合交易所有限公司证券上市规则及相关法例。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B 6月3日回购10.66万股，涉资约169.39万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640906269","title":"荃信生物-B(02509)6月3日斥资169.39万港元回购10.66万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640906269","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640906269?lang=zh_cn&edition=full","pubTime":"2026-06-03 19:08","pubTimestamp":1780484906,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)发布公告，于2026年6月3日，该公司斥资169.39万港元回购10.66万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449733.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142580307","title":"荃信生物-B6月2日回购5.72万股股份，耗资约94.42万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1142580307","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142580307?lang=zh_cn&edition=full","pubTime":"2026-06-02 20:26","pubTimestamp":1780403165,"startTime":"0","endTime":"0","summary":"江苏荃信生物医药股份有限公司于2026年6月2日公告，披露当日于香港联交所场内回购股份5.72万股，约占公司既有已发行股本的0.0255%。每股回购价格介于15.96港元至16.70港元之间，总金额约94.42万港元。根据5月29日通过的回购授权，公司可回购的股份总数为22,436,340股，截至目前，已回购231,600股，占授权通过当日已发行股份总数的约0.1032%。公司确认本次回购已遵守香港联合交易所有限公司证券上市规则及相关法律规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B6月2日回购5.72万股股份，耗资约94.42万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160882165","title":"荃信生物-B：6月1日回购17.44万股，耗资约281.47万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1160882165","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160882165?lang=zh_cn&edition=full","pubTime":"2026-06-01 21:46","pubTimestamp":1780321577,"startTime":"0","endTime":"0","summary":"荃信生物-B于2026年6月1日发布公告，披露当日在香港联合交易所回购股份的具体情况。根据公告，公司于当日回购了174,400股普通股，占该公司已发行股本约0.078%，每股回购价介乎每股15.66港元至16.54港元，合计支付约2,814,693.92港元。回购完成后，公司已发行股本下降至224,189,000股，而库存股份相应增至2,882,600股，总发行股本仍为227,071,600股。公司在公告中确认，本次回购行为已遵守香港联合交易所有限公司的相关上市规则和适用法规。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"荃信生物-B：6月1日回购17.44万股，耗资约281.47万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640395279","title":"荃信生物-B(02509)6月1日耗资约281.47万港元17.44万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2640395279","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640395279?lang=zh_cn&edition=full","pubTime":"2026-06-01 21:41","pubTimestamp":1780321314,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B(02509)公布，2026年6月1日耗资约281.47万港元17.44万股股份。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448765.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638695515","title":"荃信生物-B(02509.HK)5月28日耗资115.7万港元回购7万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638695515","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638695515?lang=zh_cn&edition=full","pubTime":"2026-05-28 20:37","pubTimestamp":1779971823,"startTime":"0","endTime":"0","summary":"格隆汇5月28日丨荃信生物-B(02509.HK)公告，5月28日耗资115.7万港元回购7万股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260528/32262016.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02509","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114579858","title":"荃信生物-B回购7万股股份，总额约115.66万港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1114579858","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114579858?lang=zh_cn&edition=full","pubTime":"2026-05-28 20:11","pubTimestamp":1779970287,"startTime":"0","endTime":"0","summary":"江苏荃信生物医药股份有限公司于2026年5月28日发布公告，披露当日在香港联交所场内回购H股合计70,000股，占公司已发行股本约0.0312%。本次回购的每股价格介乎16.21港元至16.60港元，总计支付金额1,156,589港元。公司此前于2025年6月20日获得回购授权，可回购股份总数为22,207,160股，截至本次交易日，公司已回购2,708,200股，占授权通过日已发行股份总数的1.22%。公告同时提及，该等交易严格遵守香港联交所主板上市规则及相关法律法规规定。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"荃信生物-B回购7万股股份，总额约115.66万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02509"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638880146","title":"荃信生物-B(02509)就完成QX031N I期临床试验首例受试者给药收到罗氏支付的里程碑付款","url":"https://stock-news.laohu8.com/highlight/detail?id=2638880146","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638880146?lang=zh_cn&edition=full","pubTime":"2026-05-27 20:58","pubTimestamp":1779886738,"startTime":"0","endTime":"0","summary":"智通财经APP讯，荃信生物-B 公布，公司已于2026年5月27日收到合作伙伴F.Hoffmann-LaRoche Ltd支付的里程碑付款，该付款乃基于QX031N项目完成I期临床试验首例受试者给药而触发。该研究于2026年3月27日完成首例受试者给药。于2025年10月28日，公司与罗氏达成全球独家合作与许可协议，授予罗氏开发、生产及商业化QX031N的全球独家权益。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1446843.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02509"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.qyuns.net","stockEarnings":[{"period":"1week","weight":-0.0883},{"period":"1month","weight":-0.1036},{"period":"3month","weight":-0.2079},{"period":"6month","weight":-0.2824},{"period":"1year","weight":0.0129},{"period":"ytd","weight":-0.2029}],"compareEarnings":[{"period":"1week","weight":-0.0565},{"period":"1month","weight":-0.0693},{"period":"3month","weight":-0.0515},{"period":"6month","weight":-0.0378},{"period":"1year","weight":0.0159},{"period":"ytd","weight":-0.0415}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏荃信生物医药股份有限公司是一家主要从事自身免疫及过敏性疾病的生物疗法研发、制造及商业化的中国公司。该公司专注于皮肤、风湿、呼吸道及消化道疾病。该公司的产品主要包括赛乐信、奥托奇拜单抗，以及鲁塞奇塔单抗等。该公司在国内和国外市场开展业务。","exchange":"SEHK","name":"荃信生物-B","nameEN":"QYUNS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供荃信生物-B(02509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"荃信生物-B,02509,荃信生物-B股票,荃信生物-B股票老虎,荃信生物-B股票老虎国际,荃信生物-B行情,荃信生物-B股票行情,荃信生物-B股价,荃信生物-B股市,荃信生物-B股票价格,荃信生物-B股票交易,荃信生物-B股票购买,荃信生物-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"荃信生物-B(02509)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供荃信生物-B(02509)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}